Diabetes: Nipro Dx boosts manufacturing following FDA wins for blood glucose monitors

Florida-based diabetes devices maker Nipro Diagnostics lands FDA clearance for 2 new blood glucose monitors and boosts its manufacturing capabilities ahead of a Q4 2014 launch.

Diabetes company Nipro Diagnostics touted FDA wins for a pair of new blood glucose monitors for use in home and professional settings, saying that the device maker will look to boost its manufacturing capabilities ahead of a late 2014 launch.

Nipro Diagnostics

News Well, Regulatory/Clearance, 510(k), Diabetes, Food & Drug Administration (FDA)

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pYFwWk